The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksByotrol Regulatory News (BYOT)

Share Price Information for Byotrol (BYOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10
Bid: 0.05
Ask: 0.15
Change: -0.025 (-20.00%)
Spread: 0.10 (200.00%)
Open: 0.125
High: 0.125
Low: 0.10
Prev. Close: 0.125
BYOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

24 Aug 2018 12:01

RNS Number : 8450Y
Byotrol PLC
24 August 2018
 

 

24 August 2018

 

 

 

 

 

Byotrol plc

("Byotrol", the "Company" or the "Group")

 

Director Dealing

 

 

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce that on 24 August 2018, Dr Trevor Francis, Chief Technical Officer of the Company purchased 657,686 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 3.8p per Ordinary Share (the "Purchase").

Following the Purchase, Mr. Francis has an interest in 2,910,902 Ordinary Shares representing approximately 0.68 per cent. of the total voting rights of the Company.

 

 

 

Enquiries:

 

 

Enquiries:

David Traynor - Chief Executive, Byotrol plc 01925 742 000

David Paton - Investor Relations 07714 190 474

 

 

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Tim Redfern/Richard Chambers - Corporate Broking

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

 

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

 

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk

 

 

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Francis

2.

Reason for the Notification

a)

Position/status

Chief Technical Officer

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Volume - 657,686

Price - 3.8 pence

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

24 August 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGZRGDVGRZM
Date   Source Headline
30th Jul 20094:46 pmRNSResult of AGM
9th Jul 20098:07 amRNSAnnual Report & Accounts
30th Jun 20094:37 pmRNSHolding(s) in Company
24th Jun 20099:29 amRNSDirector/PDMR Shareholding
23rd Jun 20094:57 pmRNSDirector/PDMR Shareholding
22nd Jun 20098:00 amRNSDirectorate Change
16th Jun 20097:00 amRNSFinal Results
11th May 20097:00 amRNSDirectorate Change
2nd Mar 20098:00 amRNSUpdate on Trading
28th Nov 200810:58 amRNSTotal Voting Rights
25th Nov 20081:52 pmRNSHolding(s) in Company
25th Nov 20081:51 pmRNSHolding(s) in Company
24th Nov 20081:20 pmRNSHolding(s) in Company
24th Nov 20087:00 amRNSInterim Results
20th Nov 20083:32 pmRNSHolding(s) in Company
20th Nov 200812:28 pmRNSHolding(s) in Company
19th Nov 200810:30 amRNSResult of EGM
31st Oct 20087:00 amRNSConfirmation of posting of Circular
30th Oct 20087:30 amRNSNHS Supply Chain Listing
29th Oct 200812:00 pmRNSProposed Placing / Notice of General Meeting
7th Oct 20087:00 amRNSHealthcare Update
30th Sep 200810:46 amRNSTotal Voting Rights
5th Sep 200812:00 pmRNSHolding(s) in Company
1st Sep 200811:14 amRNSDirector/PDMR Shareholding
29th Aug 20089:00 amRNSTotal Voting Rights
21st Aug 200812:37 pmRNSHolding(s) in Company Replace
20th Aug 200812:00 pmRNSHolding(s) in Company
18th Aug 20087:00 amRNSDirector/PDMR Shareholding
6th Aug 200812:18 pmRNSDirector/PDMR Shareholding
31st Jul 20083:09 pmRNSResult of AGM
18th Jul 20087:54 amRNSDirector/PDMR Shareholding
16th Jul 20087:53 amRNSDirector/PDMR Shareholding
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
4th Jul 20083:00 pmRNSAnnual Report and Accounts
3rd Jul 20084:49 pmRNSHolding(s) in Company
2nd Jul 20084:00 pmRNSHolding(s) in Company
27th Jun 20088:50 amRNSHolding(s) in Company
17th Jun 20087:00 amRNSFinal Results
29th May 20081:50 pmRNSResult of Meeting
27th Feb 20087:02 amRNSLatest developments
13th Feb 20088:57 amRNSHolding(s) in Company
5th Feb 20081:19 pmRNSHolding(s) in Company
11th Jan 200812:52 pmRNSHolding(s) in Company
19th Dec 200712:22 pmRNSHolding(s) in Company
29th Nov 20077:01 amRNSInterim Results
28th Sep 200712:02 pmRNSTotal Voting Rights
25th Sep 20073:19 pmRNSHolding(s) in Company
18th Sep 20074:50 pmRNSAdditional Listing
6th Sep 20074:44 pmRNSHolding(s) in Company
5th Sep 20077:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.